Demographic and clinical factors associated with benzodiazepine prescription at discharge from psychiatric inpatient treatment
- PMID:26139289
- PMCID: PMC4630106
- DOI: 10.1016/j.genhosppsych.2015.06.004
Demographic and clinical factors associated with benzodiazepine prescription at discharge from psychiatric inpatient treatment
Abstract
Objective: We sought to characterize diagnostic and treatment factors associated with receiving a prescription for benzodiazepines at discharge from a psychiatric inpatient unit. We hypothesized that engaging in individual behavioral interventions while on the unit would decrease the likelihood of receiving a benzodiazepine prescription at discharge.
Method: This is an observational study utilizing medical chart review (n=1007) over 37 months (2008-2011). Descriptive statistics characterized patient demographics and diagnostic/prescription frequency. Multivariate regression was used to assess factors associated with receiving a benzodiazepine prescription at discharge.
Results: The sample was 61% female with mean age=40.5 (S.D.=13.6). Most frequent diagnoses were depression (54.7%) and bipolar disorder (18.6%). Thirty-eight percent of participants engaged in an individual behavioral intervention. Benzodiazepines were prescribed in 36% of discharges. Contrary to our hypothesis, individual behavioral interventions did not influence discharge benzodiazepine prescriptions. However, several other factors did, including having a substance use disorder [odds ratio (OR)=0.40]. Male sex (OR=0.56), Black race (OR=0.40) and age (OR=1.03) were nonclinical factors with strong prescribing influence.
Conclusion: Benzodiazepines are frequently prescribed at discharge. Our results indicate strong racial and sex biases when prescribing benzodiazepines, even after controlling for diagnosis.
Keywords: Benzodiazepine; Health disparities; Inpatient treatment; Prescribing.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
None of the authors report any conflicts of interest.
Figures
Similar articles
- Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM; Centers for Disease Control and Prevention (CDC).Paulozzi LJ, et al.MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.MMWR Surveill Summ. 2015.PMID:26469747
- Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study.Sidorchuk A, Isomura K, Molero Y, Hellner C, Lichtenstein P, Chang Z, Franck J, Fernández de la Cruz L, Mataix-Cols D.Sidorchuk A, et al.PLoS Med. 2018 Aug 7;15(8):e1002635. doi: 10.1371/journal.pmed.1002635. eCollection 2018 Aug.PLoS Med. 2018.PMID:30086134Free PMC article.
- Benzodiazepine-opioid co-prescribing in a national probability sample of ED encounters.Kim HS, McCarthy DM, Mark Courtney D, Lank PM, Lambert BL.Kim HS, et al.Am J Emerg Med. 2017 Mar;35(3):458-464. doi: 10.1016/j.ajem.2016.11.054. Epub 2016 Dec 2.Am J Emerg Med. 2017.PMID:27923527
- [Systematic review of the side effects of benzodiazepines].Seldenrijk A, Vis R, Henstra M, Ho Pian K, van Grootheest D, Salomons T, Overmeire F, de Boer M, Scheers T, Doornebal-Bakker R, Ruhé HG, Vinkers CH.Seldenrijk A, et al.Ned Tijdschr Geneeskd. 2017;161:D1052.Ned Tijdschr Geneeskd. 2017.PMID:29076441Review.Dutch.
- Addiction to benzodiazepines--how common?Piper A Jr.Piper A Jr.Arch Fam Med. 1995 Nov;4(11):964-70. doi: 10.1001/archfami.4.11.964.Arch Fam Med. 1995.PMID:7582063Review.
Cited by
- Patient race and opioid misuse history influence provider risk perceptions for future opioid-related problems.Hirsh AT, Anastas TM, Miller MM, Quinn PD, Kroenke K.Hirsh AT, et al.Am Psychol. 2020 Sep;75(6):784-795. doi: 10.1037/amp0000636.Am Psychol. 2020.PMID:32915023Free PMC article.
- Factors associated with benzodiazepine prescribing in community mental health settings.Jessell L, Stanhope V, Manuel JI, Mateu-Gelabert P.Jessell L, et al.J Subst Abuse Treat. 2020 Feb;109:56-60. doi: 10.1016/j.jsat.2019.10.001. Epub 2019 Nov 22.J Subst Abuse Treat. 2020.PMID:31856952Free PMC article.
- Examining racial/ethnic differences in patterns of benzodiazepine prescription and misuse.Cook B, Creedon T, Wang Y, Lu C, Carson N, Jules P, Lee E, Alegría M.Cook B, et al.Drug Alcohol Depend. 2018 Jun 1;187:29-34. doi: 10.1016/j.drugalcdep.2018.02.011. Epub 2018 Mar 26.Drug Alcohol Depend. 2018.PMID:29626743Free PMC article.
- Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community.Johnson CF, Nassr OA, Harpur C, Kenicer D, Thom A, Akram G.Johnson CF, et al.Pharm Pract (Granada). 2018 Jul-Sep;16(3):1256. doi: 10.18549/PharmPract.2018.03.1256. Epub 2018 Sep 26.Pharm Pract (Granada). 2018.PMID:30416628Free PMC article.
- Misuse of benzodiazepines: Prevalence and impact in an inpatient population with psychiatric disorders.Panes A, Verdoux H, Fourrier-Réglat A, Berdaï D, Pariente A, Tournier M.Panes A, et al.Br J Clin Pharmacol. 2020 Mar;86(3):601-610. doi: 10.1111/bcp.14165. Epub 2020 Jan 14.Br J Clin Pharmacol. 2020.PMID:31652345Free PMC article.
References
- Ashton HC. Benzodiazepines: How do they work and how to withdraw (aka The Ashton Manual) Newcastle, UK: Institute of Neuroscience, Newcastle University; c2002. [cited 2014 Apr 14]. [Internet]. Available from:http://www.benzo.org.uk/manual/index.htm/
- Hallahan BP, Murray IT, McDonald C. Benzodiazepine and hypnotic prescribing in an acute adult psychiatric in-patient unit. Psychiatric Bulletin. 2009;33:12–14.
- Wheeler A, Kairuz T, Sheridan J, McPhee E. Sedative-Hypnotic treatment in an acute psychiatric setting: Comparison with best practice guidance. Pharm World Sci. 2007;29:603–610. - PubMed
- Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman ATF, et al. Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: Findings from the Netherlands Study of Depression and Anxiety (NESDA) J Affect Disord. 2011;131:233–242. - PubMed
- American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. 2nd Edition. American Psychiatric Association; 2009.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical